Malaria during pregnancy can be dangerous. But with growing resistance to common treatments, new solutions are needed. One promising drug is dihydroartemisinin-piperaquine (DP), which requires taking for several days. Yet, even simple, single-dose treatments often miss the mark. This issue leaves experts worried that multi-day treatments might face even lower adherence.

In Kenya, a trial showed that educating both healthcare workers and pregnant women about DP improved adherence. Health workers were trained, and tools were provided to promote understanding and proper use. The study delved into the perspectives of healthcare providers and pregnant women to understand how this targeted education helped.

Education matters because it empowers. When women know why and how to take their medication, they are more likely to follow through. Health workers, feeling supported and informed, are better equipped to guide their patients.

The trial also explored if improved adherence changed how healthcare providers saw the feasibility of multi-day treatments. If women are taking their medicine as instructed, it signals to healthcare providers that these longer treatments might work well in the real world.

Why Information Matters: How Educating Pregnant Women & Health Workers in Kenya Boosts Malaria Fight

Actions